Evidence map›Paper›PMID 42786254›Full record

ArticleCommunications chemistry2026

MEGPNM as a multiscale edge-aware GAT network with hybrid pooling predicting permeability of non-peptidic macrocycles.

Shida He, Lesong Wei, Weidong Ye, Quan Zou, Feng Zhang

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shida HeThe Joint Innovation Center for Engineering in Medicine, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Lesong WeiYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Weidong YeThe Joint Innovation Center for Engineering in Medicine, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.
Quan ZouYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.ORCID http://orcid.org/0000-0001-6406-1142
Feng ZhangThe Joint Innovation Center for Engineering in Medicine, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China. fengzhang@wmu.edu.cn.ORCID http://orcid.org/0000-0002-6751-0377

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32400544National Natural Science Foundation of China (National Science Foundation of China) 62303355
6 · The paper itself

Abstract

Non-peptidic macrocycles are attractive therapeutic candidates for targets that are difficult to drug, while still offering a path toward oral exposure. Predicting their membrane permeability, however, remains difficult because these molecules are conformationally flexible and can display molecular chameleon behavior. These properties make permeability prediction particularly challenging, so macrocycle-specific models are needed. In this work, we propose MEGPNM for permeability prediction. Our approach leverages multilayer edge-aware graph attention, incorporates Jumping Knowledge. We evaluate MEGPNM on PAMPA dataset from the Non-peptidic Macrocycle Membrane Permeability Database and benchmark it against fingerprint-based machine learning baselines and representative deep learning models, achieving the best performance. In addition, attention analyses highlight recurring structural motifs associated with permeability, providing practical clues for permeability-guided macrocycle optimization. We also release a web server for rapid permeability prediction and structure visualization to help early-stage screening.

Identifiers

PMID42786254
PMCPMC13612582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.